Skip to content
Search

Latest Stories

University of Sheffield launches new pharmacy degree to strengthen NHS workforce

University of Sheffield launches new pharmacy degree to strengthen NHS workforce

The university also offers an opportunity for qualified pharmacy technicians to gain a pharmacy degree

The University of Sheffield is launching a new four-year Master of Pharmacy (MPharm) degree programme, aimed at producing highly skilled pharmacists to boost the NHS workforce amid growing demand.

Set to begin in September 2025, the course combines a strong scientific foundation with a commitment to patient care, the university announced recently.


Students will gain hands-on experience through placements in community, hospital, and primary care settings, allowing them to apply their learning in real-world situations.

In addition, the university will offer a Master of Pharmacy with a Preparatory Year for qualified Pharmacy Technicians seeking to gain a Pharmacy degree.

“Our course is designed to produce graduates who are not only experts in medicines but also compassionate healthcare professionals who can make a real difference in people’s lives,” said Professor Susan Matthews, Head of Pharmacy at the University of Sheffield’s School of Allied Health Professions, Nursing and Midwifery.

A unique feature of the course is the “social accountability placement,” allowing students to work with over 130 community partners in the voluntary sector.

Osman Chohan, Chief Pharmacist and Chair of the Yorkshire and Humber Chief Pharmacists Network, noted that the programme will not only benefit Sheffield but also South Yorkshire and neighbouring regions.

“At a time when the NHS has significant workforce gaps and demand for NHS services is unrelenting, the prospect of a steady stream of highly skilled, highly trained pharmacists to support the local population is really exciting.”

He emphasised the important role pharmacists play in improving patient outcomes and reducing the risks associated with medications.

“Medicines are the most common intervention we make in the care of patients but medicines are not without their risks. Pharmacists are a critical part of ensuring patients get the best outcomes from their medicines whilst minimising risk and side effects,” Chohan stated.

The University of Sheffield is in the process of accrediting the programme with the General Pharmaceutical Council (GPhC), with provisional accreditation granted until the formal process is complete.

More For You

RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less